Technology
Oxford Metrics revenue, profit to top market forecasts
Sensing technology company Oxford Metrics said in a trading update on Wednesday that it was set to report total revenues of £44m for the year, surpassing current market expectations.
Halma makes two acquisitions worth up to £47m
Halma announced two strategic acquisitions with a combined maximum consideration of £46. 5m on Wednesday.
FD Technologies planning more investment as it swings to first-half loss
FD Technologies shares were tumbling on Tuesday morning after the company swung to a first-half loss due to a decline in revenue.
Softcat shares slide as revenue misses forecasts
Technology infrastructure product and service provider Softcat described a year of robust profitability and cash generation in its preliminary results on Tuesday, although its shares were sliding after revenue fell almost 9% and failed to meet market forecasts.
Plus500 reports robust third-quarter performance
Multi-asset fintech specialist Plus500 reported a robust third-quarter performance on Tuesday, during a period marked by lower market volatility and trading volumes.
Eurowag performing in line with expectations through third quarter
Commercial road transport (CRT)-focussed WAG Payment Solutions, trading as Eurowag, reported a solid performance in line with expectations for the first nine months of the year on Tuesday.
Harvest Minerals updates on challenging year for fertiliser sales
Fertiliser producer Harvest Minerals updated the market on sales for its KP Fértil product on Monday, reporting that as of the end of September, it had received orders totalling 40,000 tonnes.
Ondine reports strong research findings from Canadian hospitals
Ondine Biomedical announced ground-breaking research findings from Vancouver General and University of British Columbia (UBC) Hospitals in British Columbia, Canada, on Monday, after they implemented a universal pre-surgical nasal photodisinfection and chlorhexidine gluconate (CHG) wipes protocol.
OptiBiotix inks ingredient deal with Tata Chemicals
Life sciences developer OptiBiotix Health announced a significant agreement with Tata Chemicals on Monday, that would see its proprietary ‘Fossence’ product incorporated into their ‘SlimBiome’ and ‘LeanBiome’ product lines, specifically tailored for the Indian market.
Tesla Q3 earnings fall short of expectations
Electric vehicles manufacturer Tesla posted third-quarter quarter earnings that came in below expectations on Thursday, with chief executive Elon Musk voicing concerns regarding the state of the global economy.
i-nexus parts ways with 'major legacy customer'
Software company i-nexus said on Tuesday that a "major legacy customer" will not renew its contract with the group at the end of the calendar year.
Melrose boosts full-year guidance for margins
Aerospace outfit Melrose upgraded its full-year guidance thanks to the continued "strong" aftermarket demand in its Engines business.
Chemring receives U.S. DoD approvals for countermeasures deliveries
America's Department of Defense granted Chemring the majority of the approvals needed in order to proceed with the delivery of certain countermeasures.
Ondine announces expanded Canadian availability of Steriwave
Life sciences company Ondine Biomedical announced the expansion of the availability of its Steriwave nasal photo disinfection technology on Friday across various hospitals in Canada.
Mirriad Advertising appoints new finance chief
In-content advertising specialist Mirriad Advertising announced the appointment of Nicholos (Nic) Hellyer as its chief financial officer designate on Friday after recent strategic evaluations and a managerial reshuffle.
Digitalbox completes £0.47m acquisition of TVGuide
Digitalbox announced the successful acquisition of the web and mobile platform assets of TVGuide. co. uk on Friday, as well as the Amazon Alexa TV Guide skill.
Windward reports series of contract wins
Maritime artificial intelligence (AI) company Windward reported a series of contract triumphs and renewals throughout its second half on Thursday, affirming a trading performance aligning with market anticipations for the year.
Acquisitions underpin first-half growth for FW Thorpe
Professional lighting specialist FW Thorpe reported a 23% rise in revenue in its final results on Thursday, amounting to £176. 7m, or a 10. 7% increase when excluding the impact from the acquisition of SchalLED and Zemper.
Wise hikes guidance after strong second quarter
Payments specialist Wise upgraded its guidance on Thursday in the wake of a solid second-quarter performance.
BiVictriX posts promising preclinical data on leukaemia candidate
Biotechnology company BiVictriX Therapeutics updated the market on the pre-clinical evaluation of BVX001 on Thursday - its first-in-class ‘Bi-Cygni’ antibody drug conjugate (ADC) developed for the potential treatment of acute myeloid leukaemia (AML).